Finance

Beta
Lists
002880:SHE
Shenzhen Weiguang Biologcl Prdcts Co Ltd
CN¥21.40
-3.39%
(-0.75) 1D
Jun 24, 3:04:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002880...
Open
CN¥21.90
High
CN¥22.46
Low
CN¥21.32
Mkt. cap
4.91B
Avg. vol.
1.31M
Volume
1.40M
Dividend
0.93%
Quarterly dividend
CN¥0.05
Ex-dividend date
May 27, 2026
P/E ratio
20.78
52-wk high
CN¥33.79
52-wk low
CN¥21.05
EPS
CN¥1.03
Shares outstanding
226.80M
No. of employees
901
Open
CN¥21.90
High
CN¥22.46
Low
CN¥21.32
Mkt. cap
4.91B
Avg. vol.
1.31M
Volume
1.40M
Dividend
0.93%
Quarterly dividend
CN¥0.05
Ex-dividend date
May 27, 2026
P/E ratio
20.78
52-wk high
CN¥33.79
52-wk low
CN¥21.05
EPS
CN¥1.03
Shares outstanding
226.80M
No. of employees
901
News stories
From sources across the web
About Shenzhen Weiguang Biologcl Prdcts Co Ltd
CEO-
Employees901
Founded1985
Headquarters-
SectorBiotechnology
Websiteszwg.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
293.09M
272.80M
475.76M
221.87M
Cost of goods sold
161.14M
161.36M
313.06M
138.14M
Cost of revenue
161.14M
161.36M
313.06M
138.14M
Research and development expenses
10.04M
14.04M
10.39M
11.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.96M
34.03M
44.32M
25.10M
Operating expense
53.61M
49.12M
68.78M
41.67M
Total operating expenses
214.75M
210.48M
381.83M
179.81M
Operating income
78.34M
62.32M
93.93M
42.06M
Other non operating income
-470.02K
178.48K
-380.85K
-84.97K
EBT including unusual items
75.20M
55.89M
98.90M
39.18M
EBT excluding unusual items
74.14M
58.53M
88.53M
39.33M
Income tax expense
11.35M
5.65M
10.93M
8.41M
Effective tax rate
15.09%
10.10%
11.05%
21.46%
Other operating expenses
1.60M
-2.34M
5.70M
564.05K
Net income
63.88M
50.21M
88.46M
30.98M
Net profit margin
21.79%
18.41%
18.59%
13.96%
Earnings per share
-
-
-
-
Interest and investment income
1.59M
1.11M
829.24K
1.65M
Interest expense
-5.32M
-5.08M
-5.85M
-4.29M
Net interest expenses
-3.73M
-3.97M
-5.02M
-2.65M
Depreciation and amortization charges
-
-
-
-
EBITDA
112.57M
91.24M
131.93M
80.06M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more